and 2) inflammation and emphysema associated with increased numbers of activated alveolar macrophages (30, 35) . Genetic experiments in which SP-D was replaced with mutant SP-D protein demonstrated that phospholipid abnormalities were modulated independently of lung inflammation and emphysema (22, 36, 37) . In SP-D(Ϫ/Ϫ) mice, the normal reduction in alveolar and lung saturated phosphatidylcholine (Sat PC) pools that occurs from newborns to adults was not observed. Lung Sat PC concentrations were increased three-to fourfold in SP-D(Ϫ/Ϫ) mice at all ages (13). Surfactant phospholipids and proteins are synthesized, stored, secreted, and recycled in type II cells (33). Alveolar type II epithelial cells and alveolar macrophages contribute equally to surfactant phospholipid catabolism (6). In healthy individuals, alveolar and lung tissue surfactant pool sizes are tightly regulated. We previously demonstrated that Sat PC synthesis, secretion by alveolar type II cells, and catabolism by alveolar macrophages were normal in SP-D(Ϫ/Ϫ) mice (9). Therefore, lipid abnormalities in SP-D(Ϫ/Ϫ) mice might relate primarily to changes in surfactant uptake, catabolism, and/or recycling by type II cells. The ultrastructure of surfactant from SP-D(Ϫ/Ϫ) mice contained abnormal dense large aggregate (LA) forms (17). We hypothesized that SP-D might regulate surfactant homeostasis in the lung, at least in part by influencing the physical structure of the phospholipid-rich aggregates that, in turn, might influence their uptake and catabolism by type II epithelial cells (31). In the present study, effects of SP-D on surfactant ultrastructure and uptake by type II cells were assessed. Because surfactant pool sizes change during normal development, we also determined the role of SP-D in the modulation of surfactant ultrastructure and pool sizes during the postnatal period.
SURFACTANT PROTEIN D (SP-D) is a 43-kDa member of the collectin family of calcium-dependent lectins whose host defense function has been well recognized (4) . The critical role of SP-D in pulmonary homeostasis was not apparent until the SP-D gene-targeted mouse was developed (2, 17) . Targeted inactivation of the SP-D gene in mice [SP-D(Ϫ/Ϫ)] caused two major unexpected abnormalities in the lung: 1) marked accumulation of tissue and alveolar surfactant phospholipids (13) and 2) inflammation and emphysema associated with increased numbers of activated alveolar macrophages (30, 35) . Genetic experiments in which SP-D was replaced with mutant SP-D protein demonstrated that phospholipid abnormalities were modulated independently of lung inflammation and emphysema (22, 36, 37) . In SP-D(Ϫ/Ϫ) mice, the normal reduction in alveolar and lung saturated phosphatidylcholine (Sat PC) pools that occurs from newborns to adults was not observed. Lung Sat PC concentrations were increased three-to fourfold in SP-D(Ϫ/Ϫ) mice at all ages (13) . Surfactant phospholipids and proteins are synthesized, stored, secreted, and recycled in type II cells (33) . Alveolar type II epithelial cells and alveolar macrophages contribute equally to surfactant phospholipid catabolism (6) . In healthy individuals, alveolar and lung tissue surfactant pool sizes are tightly regulated. We previously demonstrated that Sat PC synthesis, secretion by alveolar type II cells, and catabolism by alveolar macrophages were normal in SP-D(Ϫ/Ϫ) mice (9) . Therefore, lipid abnormalities in SP-D(Ϫ/Ϫ) mice might relate primarily to changes in surfactant uptake, catabolism, and/or recycling by type II cells. The ultrastructure of surfactant from SP-D(Ϫ/Ϫ) mice contained abnormal dense large aggregate (LA) forms (17) . We hypothesized that SP-D might regulate surfactant homeostasis in the lung, at least in part by influencing the physical structure of the phospholipid-rich aggregates that, in turn, might influence their uptake and catabolism by type II epithelial cells (31) . In the present study, effects of SP-D on surfactant ultrastructure and uptake by type II cells were assessed. Because surfactant pool sizes change during normal development, we also determined the role of SP-D in the modulation of surfactant ultrastructure and pool sizes during the postnatal period.
MATERIALS AND METHODS

Mice. Swiss black wild-type [SP-D(ϩ/ϩ)] and SP-D(Ϫ/Ϫ) mice
and conditional SP-D mice, a triple transgenic mouse in which rat SP-D is expressed in response to doxycycline (Dox) [Clara cell secretory protein (CCSP)-reverse tetracycline transactivator transcription factor (rtTAϩ), (tetO) 7 ⅐ rat SP-Dϩ, mouse SP-D(Ϫ/Ϫ)], were generated as previously described (17, 38) . Breeding colonies are maintained in the vivarium at Cincinnati Children's Hospital Medical Center according to protocols approved by the Institutional Animal Care and Use Committee. Genotyping was performed by PCR analysis (13) . Expression of rat SP-D was induced in triple transgenic mice (conditional SP-D mice) by treatment from embryonic day 4 with Dox-containing food pellets (625 mg/kg; Harlan Tekland, Madison, WI) (23, 29) . Expression of SP-D was reversed when the mice were removed from Dox (Off Dox) at 6 wk of age (38) . Another group of triple transgenic mice was fed Dox at 6 wk of age (On Dox). LA surfactant and small aggregate (SA) surfactant were isolated from bronchoalveolar lavage fluid (BALF) obtained from these groups of mice.
Isolation of LA and SA. Mice were anesthetized by intraperitoneal injection of pentobarbital. Mice were exsanguinated after we severed the distal aorta. A 20-gauge blunt needle was tied into the proximal trachea. Bronchoalveolar lavage was performed five times with enough volume (ϳ0.8 -1 ml) of 15 mM NaCl to fully inflate the lung. BALF was centrifuged at 4,000 g over 0.8 M sucrose cushion for 15 min. LA surfactant was collected from the interface, diluted with 15 mM NaCl, and centrifuged again at 40,000 g for 15 min (13) . The supernatant from the 40,000 g centrifugation that contained SA surfactant was pelleted with an ultracentrifuge at 100,000 g for 48 h.
Because BALF could not be recovered from newborn mice, their surfactant was isolated from lung minces (1, 19) . Surfactant ultrastructure was assessed in the normal lungs from SP-D(ϩ/ϩ) mice at 2, 4, and 21 days of age and from SP-D(Ϫ/Ϫ) mice at 14 days (n ϭ 3 pools from 15 mice/pool). Lung tissue was cut into small (ϳ1 mm 3 ) pieces and slowly stirred in 15 mM NaCl with a magnetic stirrer for 20 min at 2°C. The lung tissue was removed from the suspension by pouring through two layers of gauze, and aliquots of the filtered suspension were used for Sat PC and SP-D analyses. LA and SA were isolated from the suspension as described for adult BALF.
Ultrastructure of surfactant. LA and SA were isolated from three pooled murine BALF samples (n ϭ 5/pool) and processed for electron microscopy using a modified protocol from Palaniyar et al. (22) . LA and SA were fixed with 2% paraformaldehyde (EM grade; Electron Microscopy Sciences, Fort Washington, PA), 2% glutaraldehyde (EM grade; Electron Microscopy Sciences), and 0.1% CaCl 2 (Sigma, St. Louis, MO) in 0.1 M sodium cacodylate buffer (SCB), pH 7.3, at 4°C for 30 min, followed by postfixation with fresh fixative at 4°C. Pellets obtained from LA and SA were washed with 0.1 M SCB, pH 7.3, incubated with 1% osmium tetroxide (Electron Microscopy Sciences) and 1.5% potassium ferrocyanide (Sigma) in 0.1 M SCB at room temperature for 2 h, and stained en bloc with 4% aqueous uranyl acetate (Electron Microscopy Sciences) at 4°C overnight. They were dehydrated through a series of graded alcohol solutions and embedded with EMbed 812 resin (Electron Microscopy Sciences). To minimize bias, the samples were coded so that the investigator was unaware of study groups. Ultrathin sections sampled from duplicated LA and SA blocks were examined with or without uranyl acetate and lead citrate poststains using a JEOL 1230 transmission electron microscope (JEOL USA, Peabody, MA). Electron micrographs of LA and SA were photographed using Kodak 4489 EM films (Kodak, Rochester, NY) or acquired digitally using an AMT Advantage Plus 2kx2k TEM charge-coupled device camera (AMT, Danvers, MA).
Sizes (diameter and surface area) of lamellated structures in LA from conditional SP-D mice, SP-D(Ϫ/Ϫ) BALF incubated with SP-D in vitro, and normal SP-D(ϩ/ϩ) mice (newborn to adulthood) were determined. The ultrathin sections (120-nm thick) were cut from duplicated epon blocks (n ϭ 4) from each group and transferred to 200 mesh copper grids. Five to ten electron micrographs were randomly taken, one section per block. Each electron micrograph was coded according to the groups and digitally acquired at a final magnification of ϫ15,000. Measurements of surface area and diameter of the lamellated structure were determined using the area and Feret's diameter routines in Image J for OS X (a public domain image analysis program developed by Wayne Rasband at the National Institutes of Health).
SP determination. The content of SP-A, SP-B, SP-C, and SP-D in BALF was analyzed by Western blot. Sat PC was measured as previously described (13) . Samples containing 1.25 nmol of Sat PC were used for SP-A and SP-D, 0.22 nmol of Sat PC were used for analysis of SP-B, and 0.65 nmol of Sat PC were used for SP-C. Antisera were from Chemicon (Temecula, CA), and immunoreactive bands were quantitated by densitometric analyses as described previously (13) . BALF was recovered from SP-D(Ϫ/Ϫ) mice using buffer containing 10 mM Tris ⅐ HCl/2.5 mM CaCl 2/1 mM MgSO4/0.1 mM EDTA/15 mM NaCl, pH 7.0. Mouse SP-D (1.5% of total phospholipid) was added to BALF from SP-D(Ϫ/Ϫ) mice and incubated at 37°C for 2 h with slow rotation. LA and SA were isolated as described above, and ultrastructure was determined.
Uptake of surfactant by murine type II cells. Type II cells were isolated from SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice and cultured as previously reported (27) . Briefly, after lungs were perfused with 10 -20 ml of sterile 15 mM NaCl via the pulmonary artery, dispase (Collaborative Research, Bedford, MA) was rapidly instilled into the lungs followed by 1% low-melt agarose warmed to 45°C. Lungs were immediately cooled with ice for 2 min and incubated in 1 ml of dispase for 45 min at room temperature. Lungs were subsequently transferred to a culture dish containing 100 U/ml of DNase I (Sigma). The tissue was gently teased from the bronchi. Cell suspensions were filtered and collected by centrifugation and placed on prewashed 100-mm tissue culture plates that had been coated with CD45 and CD32 antibodies (Pharmingen, San Diego, CA). After incubation for 2 h at 37°C in 5% CO 2, combined type II cells from four mice were resuspended and seeded into 12 wells. Type II cells were cultured on Matrigel matrix in bronchial epithelial cell growth media containing 5% charcoal-stripped FBS and 10 ng/ml of keratinocyte growth factor. The purity of type II cell preparations was Ͼ90% as assessed by modified Papanicolaou's stain (5) . Under this condition, it was recently shown that after 3 days in culture, murine type II cells actively synthesize and secrete surfactant for at least 7 days (27) .
The rate of LA or SA uptake by type II cells was studied after 5-6 days in culture. LA and SA containing 15 nmol of phospholipid were labeled by mixing with 4.8 g/well of N-rhodamine dipalmitoylphosphatidylethanolamine (Avanti Polar Lipids, Alabaster, AL) (8, 34) . Fluorescently labeled LA and SA isolated from transgenic mice were added to the cultured type II cells from SP-D(ϩ/ϩ) mice and SP-D(Ϫ/Ϫ) mice. After a 0.5-, 2-, and 4.5-h incubation, cells were carefully washed five times with PBS and extracted with methanol containing 1 mg/ml of dipalmitoylphosphatidylcholine from the wells, and fluorescence measured. Data analysis. Results are given as means Ϯ SE. Two group comparisons were carried out by unpaired Student's t-tests. Comparisons among groups were made by ANOVA with Tukey's tests used for post hoc analyses. Significance was accepted at P Ͻ 0.05.
RESULTS
Ultrastructure of LA and SA from SP-D(Ϫ/Ϫ) and SP-D(ϩ/ϩ) mice.
Ultrastructure of LA and SA isolated from SP-D(ϩ/ϩ)and SP-D(Ϫ/Ϫ) mice was determined by electron microscopy (Fig. 1, A-D) . Lamellated lipid structures in LA from normal [SP-D(ϩ/ϩ)] mice are shown. The LA fraction from SP-D(Ϫ/Ϫ) mice contained abnormally dense lipid forms (Fig. 1B) . The structure of SA was also abnormal, consisting of atypical multilamellated small vesicles (Fig. 1D) . The lamellated vesicles in SA from SP-D(Ϫ/Ϫ) mice were approximately one-third the size of lamellar bodies seen in normal LA.
Effects of SP-D on surfactant structure in vivo. In the absence of Dox, surfactant ultrastructure from the conditional SP-D(Ϫ/Ϫ) mice was similar to that in SP-D(Ϫ/Ϫ) mice (Fig.  1, B and D and Fig. 2, A and C) . Surfactant structures in the conditional SP-D(Ϫ/Ϫ) mice were changed toward that seen in SP-D(ϩ/ϩ) mice by day 14 of Dox treatment (Fig. 2B) . Likewise, the small lamellated vesicles typical of SA surfactant from SP-D(Ϫ/Ϫ) mice decreased during continued treatment with Dox (Fig. 2D) . The ultrastructure of LA and SA surfactant from conditional SP-D(Ϫ/Ϫ) mice that were continuously treated with Dox from embryonic day 4 to 6 wk of age was similar to that isolated from SP-D(ϩ/ϩ) mice (Fig. 3, A and  C) . When Dox was discontinued at 6 wk of age, abnormally dense LA forms typical of SP-D deficiency reappeared after 14 days (Fig. 3, B and D) . After removal from Dox for 14 days (Fig. 3D) , the ultrastructure of SA had changed to that typical of SP-D(Ϫ/Ϫ) mice (Fig. 1D) . Thus the removal of SP-D influenced ultrastructure of LA and SA forms in adult mice.
SP-D reverses surfactant ultrastructure in vitro.
The ultrastructure of LA and SA forms was assessed after preincubation of purified SP-D with BALF from SP-D(Ϫ/Ϫ) mice (Fig. 4) . Addition of mouse SP-D in vitro changed the abnormal largesize surfactant lipid lamellar structures typical of LA from SP-D(Ϫ/Ϫ) mice to normal-appearing lamellar bodies (Fig.  4B) . Likewise, the structure of SA was partially corrected by incubation with SP-D (Fig. 4D) .
SP-D influences the size of lamellated structures in LA in vivo and in vitro.
The surface area and diameter of lamellar bodies in LA were analyzed before and after On or Off Dox. BALF from SP-D(Ϫ/Ϫ) mice was incubated with exogenous SP-D (Fig. 5) . Surface area and diameter of lamellar bodies were decreased by replacement of SP-D [from 0 -14 days On Dox group in vivo (Fig. 5, A and B) ]. Addition of SP-D to BALF from SP-D(Ϫ/Ϫ) mice in vitro also corrected lamellar body sizes (Fig. 5, C and D) . Consistent with these findings, lamellar body size increased when Dox treatment was discontinued for 14 days (Fig. 5, A and B) .
Association of SP-D with SA. SP-D was not detectable in LA from SP-D(ϩ/ϩ) mice by Western blot. In contrast, high levels of SP-D were present in the isolated SA pellet recovered after 48 h of centrifugation at 100,000 g (Fig. 6) . In previous studies, 56% of total Sat PC in BALF was demonstrated to be associated with SA in SP-D(ϩ/ϩ) mice (13) . Therefore, the mean SP-D level relative to Sat PC in isolated SA was 60% higher than that in BALF from SP-D(ϩ/ϩ) mice. Most of the SP-D in BALF was associated with SA, and the SP-D recovered in SA (Fig. 7) . In the absence of Dox, SP-D was undetectable and increased dramatically after treatment with Dox. After 21 days On Dox, SP-D levels in BALF were similar to those in BALF from SP-D(ϩ/ϩ) mice (Fig. 6) . SP-B and SP-C levels were increased twofold in the SP-D(Ϫ/Ϫ) mice as previously observed (13) . SP-B and SP-C content was restored when the mice were treated with Dox. SP-A content was not influenced by Dox, thus correction of SA ultrastructure was mediated by changes in SP-D rather than SP-A. When adult conditional SP-D(Ϫ/Ϫ) mice were removed from Dox, SP-D content decreased (Fig. 8) . SP-A decreased and SP-B significantly increased after removal of Dox. Thus effects of SP-D on SP concentrations were reversed when the conditional SP-D(Ϫ/Ϫ) mice were removed from Dox.
Surfactant LA and SA uptake by type II cells. Uptake of LA and SA surfactant increased with time of incubation (Fig. 9) . The uptake of SA surfactant was generally greater than that of LA forms. Surfactant uptake was consistently influenced by the origin of the surfactant. in adults. The enlarged lamellated structures seen in LA from 2-and 4-day-old mice ( Fig. 12, A and B) were similar to those seen in adult SP-D(Ϫ/Ϫ) mice (Fig. 1, B and D) . Surfactant ultrastructure was similar to that in adults by 21 days of age (Fig. 12E) . Lamellated structures were seen in SA from normal newborn mice (Fig. 12, C and D, arrows) . The surface area and diameter of lamellar bodies in LA from newborn SP-D(ϩ/ϩ) mice were larger. Lamellar body size decreased to the adult size by 21 days of age (Fig. 5, E and F) .
The larger lamellar body size characteristic of newborn mice was not associated with decreased concentrations of SP-A or SP-D. SP-D and SP-A levels, relative to Sat PC, were higher in newborn than in adult lung (Fig. 13A) . As shown in Fig. 12 , ultrastructure of surfactant was similar in newborn SP-D(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice. Uptake of newborn SA by type II cells was decreased compared with that from normal adults (Fig.  13B) . This low surfactant uptake by type II cells was associated with higher surfactant pool size seen in normal newborn lungs (13) . In SP-D(Ϫ/Ϫ) mice, the normal developmental change in surfactant ultrastructure and uptake by type II cells do not occur. Thus SP-D is required for the normal postnatal changes in surfactant ultrastructure and metabolism that occurs following birth.
DISCUSSION
Our previous metabolic and genetic studies showed that SP-D regulates surfactant pool size by influencing surfactant catabolism in type II epithelial cells rather than in alveolar macrophages (13) . In SP-D(Ϫ/Ϫ) mice, surfactant phospholipid synthesis, secretion by type II cells, and catabolism of alveolar macrophages were normal (9, 13) . The present study demonstrates that uptake of surfactant by type II cells is closely associated with changes in structure of LA and SA surfactant that are dependent on SP-D. 3 and 4) , and in normal adult (lanes 5, 6, and 7) mice. SP-A and SP-D levels in BALF from normal neonatal mice were higher than in adult mice. Although the ultrastructure of LA from neonatal mice was similar to that seen in SP-D(Ϫ/Ϫ) mice, SP-D levels relative to Sat PC were higher in the neonate than in adult mice. B: uptake of surfactant by type II cells was determined. Uptake of SA from newborn mice by wild-type type II cells was significantly decreased compared with that from adult SP-D(ϩ/ϩ) mice. Uptake of LA by type II cells was less than SA and similar between adult and newborn surfactant. Uptake of newborn surfactant and adult surfactant was similar. *P Ͻ 0.05 vs. adult surfactant; n ϭ 4 separate experiments/group. mechanisms by which SP-D affects surfactant structure are unclear but may be dependent on the interaction of SP-D with phosphatidylinositol and fatty acids (21, 24) . Addition of SP-D to phospholipid vesicles containing phosphatidylinositol and SP-B reconstituted highly ordered tubular arrays in vitro (25) .
Alveolar type II cells and alveolar macrophages equally contribute to surfactant phospholipid catabolism (6) . Surfactant taken up by type II cells were either recycled or catabolized, whereas all surfactant taken up by macrophage were catabolized. In the gene-targeted mouse models of GM-CSF-deficient mice (11) , GM common receptor ␤-chain-deficient mice (26) , and acid sphingomyelinase-deficient mice lung (12), surfactant Sat PC was increased four-to eightfold in the lung. Defects in surfactant pool sizes in these mice were caused by defects in surfactant catabolism by alveolar macrophages. Although the levels of accumulation of surfactant phospholipids in the lungs of those models were similar to that seen in SP-D(Ϫ/Ϫ) mice, the mechanisms by which surfactant pools were increased are distinct. Rates of surfactant uptake and catabolism by alveolar macrophages were normal in SP-D(Ϫ/Ϫ) mice (9) . Whereas surfactant uptake by alveolar macrophages was not dependent on physical forms of surfactant or the presence of SPs (20) , its uptake by type II cells was more selective. In studies using electron-dense tracers of different molecular sizes and charges, including native (anionic) ferritin, cationic ferritin, 70-kDa dextran, and colloidal carbon, type II cells only took up cationic ferritin (31) . Endocytosis of particles by alveolar type II cells was selective and affected by charge and size (18, 31) .
SP-A levels are consistently decreased in SP-D(Ϫ/Ϫ) mice (13, 17) and conditional SP-D mice following discontinuance of Dox. Whereas SP-A played a critical role in the formation of tubular myelin, surfactant metabolism was normal in SP-A(Ϫ/Ϫ) mice (16) , and changes in SP-A do not account for changes in ultrastructure or uptake seen in SP-D(Ϫ/Ϫ) mice. Restoration of SP-D in the conditional SP-D(Ϫ/Ϫ) mice did not normalize levels of SP-A after 21 days on Dox, a time when surfactant ultrastructure and uptake were fully corrected. The present and previous (38) studies demonstrated that the replacement of SP-D in vivo normalized Sat PC levels within 14 days.
Surfactant pool sizes are highest in newborn animals (9, 15) and decrease dramatically with advancing age to the normal adult level. Mechanisms accounting for the postnatal adjustment of surfactant pool sizes are not known. Slower clearance and longer half-life of secreted surfactant in newborn lung compared with adult lung have been shown previously in rabbit and sheep in vivo (10, 14) . Lower uptake of newborn surfactant by type II cells demonstrated in the present studies may contribute to slower surfactant clearance and higher surfactant pool sizes in the newborn lung. SP-D levels are higher in newborn mice than in adult mice, perhaps indicating a role for SP-D in developmental adjustment of surfactant uptake. The structural forms of surfactant also change in the postnatal period (3) . Paradoxically, ultrastructure of surfactant from newborns is similar to that from SP-D(Ϫ/Ϫ) mice. The ultrastructure of surfactant rapidly changes postnatally and occurs in temporal association with decreased surfactant pool size. Neither surfactant pool size nor surfactant ultrastructure matures in SP-D(Ϫ/Ϫ) mice, but both are rapidly normalized by replacement of SP-D in adult mice, demonstrating that the normal maturation of surfactant pool sizes and ultrastructure are dependent on SP-D.
In summary, SP-D determines the normal ultrastructure of surfactant aggregates in the alveoli, influencing uptake of surfactant by type II cells that in turn determine pulmonary surfactant pool sizes.
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